These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Studies on the interaction of reserpine, d-amphetamine, apomorphine and 5-hydroxytryptophan. Goetz C; Klawans HL Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):119-30. PubMed ID: 4547506 [No Abstract] [Full Text] [Related]
4. Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment. Klawans HL; D'Amico DJ; Patel BC Psychopharmacologia; 1975 Nov; 44(3):297-300. PubMed ID: 1082146 [TBL] [Abstract][Full Text] [Related]
5. The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity. Klawans HL; D'amico DJ; Nausieda PA; Weiner WJ Psychopharmacology (Berl); 1977 Nov; 55(1):49-52. PubMed ID: 414261 [No Abstract] [Full Text] [Related]
6. A new animal model for schizophrenia: cholinergic and serotonergic modulation. Borison RL; Havdala HS; Diamond BI Commun Psychopharmacol; 1978; 2(3):209-14. PubMed ID: 308873 [No Abstract] [Full Text] [Related]
7. Serotonergic and cholinergic involvement in habituation of activity and spontaneous alternation of rats in a Y maze. Swonger AK; Rech RH J Comp Physiol Psychol; 1972 Dec; 81(3):509-22. PubMed ID: 4265289 [No Abstract] [Full Text] [Related]
8. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Creese I; Iversen SD Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950 [No Abstract] [Full Text] [Related]
9. The influence of antiserotonergic agents on the action of dopaminergic drugs. Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371 [TBL] [Abstract][Full Text] [Related]
11. The role of serotonergic and cholinergic systems in the aggression-stereotypy complex produced by amphetamine in mice. Roliński Z Pol J Pharmacol Pharm; 1977; 29(6):591-602. PubMed ID: 304574 [TBL] [Abstract][Full Text] [Related]
13. Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo. Sharp T; Zetterström T; Ljungberg T; Ungerstedt U Eur J Pharmacol; 1986 Oct; 129(3):411-5. PubMed ID: 3780853 [TBL] [Abstract][Full Text] [Related]
14. An experimental model of tardive dyskinesia. Klawans HL; Rubovits R J Neural Transm; 1972; 33(3):235-46. PubMed ID: 4674512 [No Abstract] [Full Text] [Related]
15. Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor. Ray SK; Poddar MK Eur J Pharmacol; 1990 Jun; 181(3):159-66. PubMed ID: 1696544 [TBL] [Abstract][Full Text] [Related]
17. Modification of amphetamine effects by intracerebrally administered anticholinergic agents. Costall B; Naylor RJ Life Sci I; 1972 Mar; 11(5):239-53. PubMed ID: 4675889 [No Abstract] [Full Text] [Related]
18. Differential effects of serotonin on turning and sterotypy induced by apomorphine. Baldessarini RJ; Amatruda TT; Griffith FF; Gerson S Brain Res; 1975 Jul; 93(1):158-63. PubMed ID: 124619 [No Abstract] [Full Text] [Related]
19. Pharmacological profile of a model for central serotonin receptor activation. Matthews WD; Smith CD Life Sci; 1980 Apr; 26(17):1397-403. PubMed ID: 6247593 [No Abstract] [Full Text] [Related]
20. Failure of antiserotonergic agents to modify levallorphan-induced stereotypy in rats. Phillips KC; Wray SR Psychopharmacologia; 1975; 41(3):263-5. PubMed ID: 125429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]